# Health Outcomes Solutions (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/health-outcomes-solutions-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 37.7 |
| Citations | 150,378 |
| City | Winter Park |
| Country | US |
| Description | Health Outcomes Solutions (United States) is a research organisation in Winter Park, US. OpenAlex records 2,926 works and 150,378 citations for it. 689 researchers list it as their most recent affiliation. |
| Homepage | http://healthoutcomessolutions.com |
| OpenAlex ID | https://openalex.org/I4210099913 |
| Region | Florida |
| Researchers | 689 |
| ROR ID | https://ror.org/0173ksf49 |
| Type | company |
| Works | 2,926 |

## University papers

Showing 12 of 13.

- [Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial](https://scholariq.org/papers/mogamulizumab-versus-vorinostat-in-previously-treated-cutaneous-t-cell-lymphoma/)
- [Measuring the side effects of taxane therapy in oncology](https://scholariq.org/papers/measuring-the-side-effects-of-taxane-therapy-in-oncology/)
- [Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission](https://scholariq.org/papers/bone-marrow-transplants-from-hla-identical-siblings-as-compared-with/)
- [Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study](https://scholariq.org/papers/quality-of-life-in-patients-with-newly-diagnosed-chronic-phase-chronic-myeloid/)
- [Ambulatory Continuous Femoral Nerve Blocks Decrease Time to Discharge Readiness after Tricompartment Total Knee Arthroplasty](https://scholariq.org/papers/ambulatory-continuous-femoral-nerve-blocks-decrease-time-to-discharge-readiness/)
- [Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial](https://scholariq.org/papers/lenvatinib-versus-sorafenib-for-first-line-treatment-of-unresectable/)
- [Atherosclerotic risk factor reduction in peripheral arterial disease](https://scholariq.org/papers/atherosclerotic-risk-factor-reduction-in-peripheral-arterial-disease/)
- [Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/effect-of-apalutamide-on-health-related-quality-of-life-in-patients-with-non/)
- [Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/quality-of-life-in-patients-with-recurrent-ovarian-cancer-treated-with-niraparib/)
- [Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials](https://scholariq.org/papers/effect-of-adalimumab-on-visual-functioning-in-patients-with-noninfectious/)
- [Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant](https://scholariq.org/papers/meaningful-change-in-depression-symptoms-assessed-with-the-patient-health/)
- [Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-locally-advanced-or-metastatic/)

## University researchers

- [Stacie Hudgens](https://scholariq.org/researchers/stacie-hudgens/)
- [Amy G. Edgecomb](https://scholariq.org/researchers/amy-g-edgecomb/)

## University top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Musculoskeletal pain and rehabilitation](https://scholariq.org/topics/musculoskeletal-pain-and-rehabilitation/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.